Insights
Search Results
Client Highlights
2.26.26
Wilson Sonsini Advises Eventus on Majority Investment by Terminus Capital Partners
On February 26, 2026, Terminus Capital Partners (TCP), a growth‑oriented private equity firm focused on majority investments in B2B software companies, and Eventus, a leading provider of comprehensive, at-scale trade surveillance and financial risk solutions, announced that TCP has acquired majority control in Eventus, positioning the firm for accelerated geographical expansion and growth in its product offerings. Wilson Sonsini Goodrich & Rosati advised Eventus on the transaction.
Client Highlights
9.23.25
Wilson Sonsini Advises AmplifAI on $33.7 Million Series B
On September 23, 2025, AmplifAI, a leading AI-powered platform transforming enterprise contact center performance, announced it has raised $33.7 million in Series B funding and credit facility. The round was led by CVS Health Ventures, with participation from existing investors LiveOak Ventures and Dallas Venture Partners. This investment will accelerate AmplifAI’s mission to unify human and AI agent performance and deliver best-in-class customer experience at scale. Wilson Sonsini Goodrich & Rosati advised AmplifAI on the transaction.
Client Highlights
7.25.25
Wilson Sonsini Advises Revival on Strategic Partnership with Olympus
On July 25, 2025, Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech, announced a strategic partnership with Olympus Corporation (Olympus), a global healthcare leader committed to making people’s lives healthier, safer, and more fulfilling through advanced medical technologies and solutions. The partnership is aimed at harnessing external innovation to accelerate development and market entry for an endoluminal robotics platform initially targeting gastrointestinal (GI) treatments. Wilson Sonsini Goodrich & Rosati advised Revival on the transaction and on fund matters related to the transaction.
Client Highlights
3.26.25
Wilson Sonsini Advises Lumata Health on $23 Million Series B
On March 5, 2025, Lumata Health, a leader in personalized support for patients with vision-threatening chronic eye diseases, announced that it has raised $23 million in Series B funding to accelerate its mission of eliminating preventable vision loss, bringing its total raised since inception to $36 million. The round was co-led by LRVHealth, McKesson Ventures, and Cencora Ventures, with participation from existing investors, including Cortado Ventures. The investment will enable Lumata to meet growing demand and further enhance the data-driven technology powering its patient adherence solutions.
Client Highlights
7.12.24
Wilson Sonsini Advises Seismos on $15 Million Growth Investment Led by Edison Partners
On July 10, 2024, Seismos, Inc., a leader in AI-powered Acoustic Sensing, and growth equity firm Edison Partners announced a $15 million growth investment to enable and accelerate the energy industry’s shift from analog-focused exploration and production to technology-driven, digital infrastructure, and autonomous production operations. Wilson Sonsini Goodrich & Rosati advised Seismos on the transaction.